Market Growth Driven by Declining Sequencing Costs, Rising Prevalence of Genetic Disorders, Expanding Clinical Applications, and Technologica ...

Solexa, Inc., later acquired by Illumina, released its platform, which combines sequencing-by-synthesis chemistry and cluster technology, in June 2006 (see 'Creating the Genome Analyzer').

Pharmacogenomics Whole genome sequencing looks not only at the DNA of the tumor cells, but also at so-called germline DNA in a child's healthy cells.

When people think of DNA, they usually think of genes, the parts that code for proteins and drive inherited traits. But there ...

SPT Labtech, a global leader in life sciences automation solutions, today announced its inclusion in an Illumina partnership ...

Regeneron and Illumina have joined a major investment in health data specialist Truveta that will support the creation of a major new genome project.

A New Era for Embryo Screening: Juniper Genomics Debuts with World’s First Whole-Genome and Transcriptome Test ...